PLAY PODCASTS
94. Liek na Alzheimera: Nová nádej či premrhané miliardy?
Episode 94

94. Liek na Alzheimera: Nová nádej či premrhané miliardy?

Pravidelná dávka

October 25, 201920m 4s

Audio is streamed directly from the publisher (mcdn.podbean.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Alzheimerova choroba patrí medzi najzávažnejšie ochorenia. Inžinieri, lekári a vedci sa už dlhé roky snažia vyvinúť liek na túto chorobu. Tento týždeň svetovými médiami preletela správa o možnej nádeji pre pacientov, ktorú poskytuje nový liek od spoločnosti Biogen.

----more----

V ďalšej epizóde Pravidelnej Dávky o inováciách v medicíne Miro rozpráva o mozgu, Alzheimerovej chorobe a o novom lieku na túto chorobu.

Referencie:

[1] Mazzotti, D. R., Guindalini, C., Moraes, W. A. D. S., Andersen, M. L., Cendoroglo, M. S., Ramos, L. R., & Tufik, S. (2014). Human longevity is associated with regular sleep patterns, maintenance of slow wave sleep, and favorable lipid profile. Frontiers in Aging Neuroscience, 6, 134. https://doi.org/10.3389/fnagi.2014.00134

[2] Grandner, M. A. (2012). Sleep duration across the lifespan: implications for health. Sleep Medicine Reviews, 16(3), 199–201. https://doi.org/10.1016/j.smrv.2012.02.001

[3] https://www.nhs.uk/conditions/alzheimers-disease/

[4] Tanzi, R. E. (2012). The Genetics of Alzheimer Disease. Cold Spring Harbor Perspectives in Medicine, 2(10), a006296–a006296. https://doi.org/10.1101/cshperspect.a006296

[5] Gerstner, W., Kistler, W. M., Naud, R., & Paninski, L. (n.d.). Neuronal dynamics : from single neurons to networks and models of cognition.

[6] Alzheimer’s drug revival gives hope to millions — and investors | Financial Times. (n.d.). Retrieved October 25, 2019, from https://www.ft.com/content/e6046166-f4f4-11e9-b018-3ef8794b17c6

[7] In Shocking Reversal, Biogen to Submit Experimental Alzheimer’s Drug for Approval - Scientific American. (n.d.). Retrieved October 25, 2019, from https://www.scientificamerican.com/article/in-shocking-reversal-biogen-to-submit-experimental-alzheimers-drug-for-approval/

***

Dobré veci potrebujú svoj čas. Pomohla ti táto dávka zamyslieť sa nad niečím zmysluplným? Podpor tvoj obľúbený podcast sumou 1€, 5€ alebo 10€ (trvalý príkaz je topka!) na SK1283605207004206791985. Ďakujeme! Viac info o podpore na pravidelnadavka.sk/#chcem-podporit